Corrigendum to 'Exploration of novel pyrrolo[2,1-f][1,2,4]triazine derivatives with improved anticancer efficacy as dual inhibitors of c-Met/VEGFR-2' [European journal of medicinal chemistry 158 (2018) 814-831].